1 / 9

Treatment as prevention: why?

Treatment as prevention: why?. Gus Cairns Editor, HIV Treatment Update. HIV diagnoses. Condom use in UK gay men. Treatment as prevention: evidence?. Montaner, Lancet 376: 532 – 539, 2010. BC study again. San Francisco. Das-Douglas, CROI 2010, abstract #33.

vera-turner
Télécharger la présentation

Treatment as prevention: why?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Treatment as prevention: why? Gus Cairns Editor, HIV Treatment Update

  2. HIV diagnoses NAT Treatment as Prevention

  3. Condom use in UK gay men NAT Treatment as Prevention

  4. Treatment as prevention: evidence? NAT Treatment as Prevention Montaner, Lancet 376: 532 – 539, 2010

  5. BC study again NAT Treatment as Prevention

  6. San Francisco Das-Douglas, CROI 2010, abstract #33 NAT Treatment as Prevention

  7. What would it take in San Francisco? • In San Francisco 85.5% are diagnosed of whom 78% are linked to care of whom 90% are on ARVs of whom 72% are undetectable = 43.2% of people with HIV in San Francisco have an undetectable viral load (due to treatment) NAT Treatment as Prevention

  8. Imperial College mathematical model • Getting 80% of people with CD4 under 350 on treatment would be enough to reduce transmission by >90% if: • Lower-risk pops tested every 2-3 years • High-risk pops test every 6m • Dodd PJ, Garnett GP, Hallett TB. Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS 24: 729-735, 2010 NAT Treatment as Prevention

  9. A wild card: PrEP • IPrEx study, results 2 days ago • 44% efficacy on 51% adherence • Potentially 70-90% efficacy: cf condoms • Practical? Affordable? Applicable? Dangerous? • We may need to start thinking of ARVs-as-prevention for HIV-negative as well as HIV-positive people • ?Pilot study of ARV treatment for high-risk HIV-negative testers nested within TasP project? NAT Treatment as Prevention Grant RM et al. Preexposure chemoprophylaxis for HIV prevention in men. New Engl Jour Med 23 November 2010.

More Related